Histone deacetylase inhibitor KBH-A42 inhibits cytokine production in RAW 264.7 macrophage cells and in vivo endotoxemia model

Yongseok Choi, Song Kyu Park, Mook Kim Hwan, Soon Kang Jong, Dae Yoon Yeo, Bae Han Sang, Whan Han Jeung, Sun Yang Jee, Gyoonhee Han

Research output: Contribution to journalArticle

46 Citations (Scopus)

Abstract

In light of the anti-inflammatory properties of histone deacetylase (HDAC) inhibitors, such as suberoylanilide hydroxamic acid (SAHA) and trichostatin A (TSA), we examined a new HDAC inhibitor KBH-A42 for its anti-inflammatory activities. KBH-A42 showed noteworthy anti-inflammatory properties in vitro via suppression of the production of TNF-α, a proinflammatory cytokine, and nitric oxide (NO), a proinflammatory effector molecule, in LPS-stimulated RAW264.7 cells and peritoneal macrophages. It also inhibited TNF-α production in vivo as demonstrated in a LPS-induced mouse endotoxemia model. The levels of TNF-α, IL-1β, IL-6 and iNOS mRNAs determined by RT-PCR propose that the inhibition of these pro-inflammatory mediators by KBH-A42 resulted from inhibiting expression of these genes. However, the EMSA study to see the effect of KBH-A42 on the binding of NF-κB, a transcription factor, to a specific DNA sequence showed that the binding of NF-κB to DNA was not changed regardless of increasing the concentration of KBH-A42 in the presence and absence of LPS stimulation. Interestingly, DNA binding of another transcription factor AP-1 dose-dependently increased by KBH-A42. KBH-A42 differentially regulated the phosphorylation of MAP kinases. While the phosphprylation of ERK1/2 and SAPK/JNK was not affected by KBH-A42, the phosphorylation of p38 decreased by KBH-A42. These results showed that KBH-A42 inhibits production of proinflammatory cytokines in macrophages by decreasing their mRNA levels, and p38 kinase is involved in the KBH-A42-mediated inhibition.

Original languageEnglish
Pages (from-to)574-581
Number of pages8
JournalExperimental and Molecular Medicine
Volume40
Issue number5
DOIs
Publication statusPublished - 2008 Oct 1

Fingerprint

Histone Deacetylase Inhibitors
Endotoxemia
Macrophages
Cytokines
Phosphorylation
Anti-Inflammatory Agents
trichostatin A
RAW 264.7 Cells
KBH A42
Phosphotransferases
Messenger RNA
DNA sequences
DNA
Transcription Factor AP-1
Peritoneal Macrophages
Interleukin-1
Interleukin-6
Nitric Oxide
Transcription Factors
Genes

Keywords

  • Anti-inflammatory agents
  • Histone deacetylases
  • NF-κ B
  • Nitric oxide
  • Transcription factor AP-1
  • Tumor necrosis factor-α
  • Vorinostat

ASJC Scopus subject areas

  • Biochemistry
  • Molecular Biology
  • Molecular Medicine
  • Clinical Biochemistry

Cite this

Histone deacetylase inhibitor KBH-A42 inhibits cytokine production in RAW 264.7 macrophage cells and in vivo endotoxemia model. / Choi, Yongseok; Park, Song Kyu; Hwan, Mook Kim; Jong, Soon Kang; Yeo, Dae Yoon; Sang, Bae Han; Jeung, Whan Han; Jee, Sun Yang; Han, Gyoonhee.

In: Experimental and Molecular Medicine, Vol. 40, No. 5, 01.10.2008, p. 574-581.

Research output: Contribution to journalArticle

Choi, Yongseok ; Park, Song Kyu ; Hwan, Mook Kim ; Jong, Soon Kang ; Yeo, Dae Yoon ; Sang, Bae Han ; Jeung, Whan Han ; Jee, Sun Yang ; Han, Gyoonhee. / Histone deacetylase inhibitor KBH-A42 inhibits cytokine production in RAW 264.7 macrophage cells and in vivo endotoxemia model. In: Experimental and Molecular Medicine. 2008 ; Vol. 40, No. 5. pp. 574-581.
@article{d8a5a9491889423593ceed1b1a913082,
title = "Histone deacetylase inhibitor KBH-A42 inhibits cytokine production in RAW 264.7 macrophage cells and in vivo endotoxemia model",
abstract = "In light of the anti-inflammatory properties of histone deacetylase (HDAC) inhibitors, such as suberoylanilide hydroxamic acid (SAHA) and trichostatin A (TSA), we examined a new HDAC inhibitor KBH-A42 for its anti-inflammatory activities. KBH-A42 showed noteworthy anti-inflammatory properties in vitro via suppression of the production of TNF-α, a proinflammatory cytokine, and nitric oxide (NO), a proinflammatory effector molecule, in LPS-stimulated RAW264.7 cells and peritoneal macrophages. It also inhibited TNF-α production in vivo as demonstrated in a LPS-induced mouse endotoxemia model. The levels of TNF-α, IL-1β, IL-6 and iNOS mRNAs determined by RT-PCR propose that the inhibition of these pro-inflammatory mediators by KBH-A42 resulted from inhibiting expression of these genes. However, the EMSA study to see the effect of KBH-A42 on the binding of NF-κB, a transcription factor, to a specific DNA sequence showed that the binding of NF-κB to DNA was not changed regardless of increasing the concentration of KBH-A42 in the presence and absence of LPS stimulation. Interestingly, DNA binding of another transcription factor AP-1 dose-dependently increased by KBH-A42. KBH-A42 differentially regulated the phosphorylation of MAP kinases. While the phosphprylation of ERK1/2 and SAPK/JNK was not affected by KBH-A42, the phosphorylation of p38 decreased by KBH-A42. These results showed that KBH-A42 inhibits production of proinflammatory cytokines in macrophages by decreasing their mRNA levels, and p38 kinase is involved in the KBH-A42-mediated inhibition.",
keywords = "Anti-inflammatory agents, Histone deacetylases, NF-κ B, Nitric oxide, Transcription factor AP-1, Tumor necrosis factor-α, Vorinostat",
author = "Yongseok Choi and Park, {Song Kyu} and Hwan, {Mook Kim} and Jong, {Soon Kang} and Yeo, {Dae Yoon} and Sang, {Bae Han} and Jeung, {Whan Han} and Jee, {Sun Yang} and Gyoonhee Han",
year = "2008",
month = "10",
day = "1",
doi = "10.3858/emm.2008.40.5.574",
language = "English",
volume = "40",
pages = "574--581",
journal = "Experimental and Molecular Medicine",
issn = "1226-3613",
publisher = "Korean Society of Med. Biochemistry and Mol. Biology",
number = "5",

}

TY - JOUR

T1 - Histone deacetylase inhibitor KBH-A42 inhibits cytokine production in RAW 264.7 macrophage cells and in vivo endotoxemia model

AU - Choi, Yongseok

AU - Park, Song Kyu

AU - Hwan, Mook Kim

AU - Jong, Soon Kang

AU - Yeo, Dae Yoon

AU - Sang, Bae Han

AU - Jeung, Whan Han

AU - Jee, Sun Yang

AU - Han, Gyoonhee

PY - 2008/10/1

Y1 - 2008/10/1

N2 - In light of the anti-inflammatory properties of histone deacetylase (HDAC) inhibitors, such as suberoylanilide hydroxamic acid (SAHA) and trichostatin A (TSA), we examined a new HDAC inhibitor KBH-A42 for its anti-inflammatory activities. KBH-A42 showed noteworthy anti-inflammatory properties in vitro via suppression of the production of TNF-α, a proinflammatory cytokine, and nitric oxide (NO), a proinflammatory effector molecule, in LPS-stimulated RAW264.7 cells and peritoneal macrophages. It also inhibited TNF-α production in vivo as demonstrated in a LPS-induced mouse endotoxemia model. The levels of TNF-α, IL-1β, IL-6 and iNOS mRNAs determined by RT-PCR propose that the inhibition of these pro-inflammatory mediators by KBH-A42 resulted from inhibiting expression of these genes. However, the EMSA study to see the effect of KBH-A42 on the binding of NF-κB, a transcription factor, to a specific DNA sequence showed that the binding of NF-κB to DNA was not changed regardless of increasing the concentration of KBH-A42 in the presence and absence of LPS stimulation. Interestingly, DNA binding of another transcription factor AP-1 dose-dependently increased by KBH-A42. KBH-A42 differentially regulated the phosphorylation of MAP kinases. While the phosphprylation of ERK1/2 and SAPK/JNK was not affected by KBH-A42, the phosphorylation of p38 decreased by KBH-A42. These results showed that KBH-A42 inhibits production of proinflammatory cytokines in macrophages by decreasing their mRNA levels, and p38 kinase is involved in the KBH-A42-mediated inhibition.

AB - In light of the anti-inflammatory properties of histone deacetylase (HDAC) inhibitors, such as suberoylanilide hydroxamic acid (SAHA) and trichostatin A (TSA), we examined a new HDAC inhibitor KBH-A42 for its anti-inflammatory activities. KBH-A42 showed noteworthy anti-inflammatory properties in vitro via suppression of the production of TNF-α, a proinflammatory cytokine, and nitric oxide (NO), a proinflammatory effector molecule, in LPS-stimulated RAW264.7 cells and peritoneal macrophages. It also inhibited TNF-α production in vivo as demonstrated in a LPS-induced mouse endotoxemia model. The levels of TNF-α, IL-1β, IL-6 and iNOS mRNAs determined by RT-PCR propose that the inhibition of these pro-inflammatory mediators by KBH-A42 resulted from inhibiting expression of these genes. However, the EMSA study to see the effect of KBH-A42 on the binding of NF-κB, a transcription factor, to a specific DNA sequence showed that the binding of NF-κB to DNA was not changed regardless of increasing the concentration of KBH-A42 in the presence and absence of LPS stimulation. Interestingly, DNA binding of another transcription factor AP-1 dose-dependently increased by KBH-A42. KBH-A42 differentially regulated the phosphorylation of MAP kinases. While the phosphprylation of ERK1/2 and SAPK/JNK was not affected by KBH-A42, the phosphorylation of p38 decreased by KBH-A42. These results showed that KBH-A42 inhibits production of proinflammatory cytokines in macrophages by decreasing their mRNA levels, and p38 kinase is involved in the KBH-A42-mediated inhibition.

KW - Anti-inflammatory agents

KW - Histone deacetylases

KW - NF-κ B

KW - Nitric oxide

KW - Transcription factor AP-1

KW - Tumor necrosis factor-α

KW - Vorinostat

UR - http://www.scopus.com/inward/record.url?scp=57349114027&partnerID=8YFLogxK

UR - http://www.scopus.com/inward/citedby.url?scp=57349114027&partnerID=8YFLogxK

U2 - 10.3858/emm.2008.40.5.574

DO - 10.3858/emm.2008.40.5.574

M3 - Article

VL - 40

SP - 574

EP - 581

JO - Experimental and Molecular Medicine

JF - Experimental and Molecular Medicine

SN - 1226-3613

IS - 5

ER -